Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 158084, 6 pages
http://dx.doi.org/10.1155/2012/158084
Research Article

Clinical Value of CD24 Expression in Retinoblastoma

1Department of Ophthalmology, Research Institute of Surgery and Daping Hospital, Third Military Medical University, Chongqing, 400042, China
2Department of Pharmacy, Chongqing Red Cross Hospital, Chongqing 400020, China
3Department of Neonatology, Yong Chuan Affiliated Hospital, Chongqing Medical University, Chongqing 402160, China

Received 10 December 2011; Accepted 6 February 2012

Academic Editor: Xin-Yuan Guan

Copyright © 2012 Jia Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Mallikarjuna, C. S. Sundaram, Y. Sharma et al., “Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors,” Proteomics—Clinical Applications, vol. 4, no. 4, pp. 449–463, 2010. View at Google Scholar · View at Scopus
  2. S. Vandhana, P. R. Deepa, U. Jayanthi, J. Biswas, and S. Krishnakumar, “Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an indian cohort study,” Experimental and Molecular Pathology, vol. 90, no. 1, pp. 29–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Indovina, A. Acquaviva, G. De Falco et al., “Downregulation and aberrant promoter methylation of p16ink4a: a possible novel heritable susceptibility marker to retinoblastoma,” Journal of Cellular Physiology, vol. 223, no. 1, pp. 143–150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kase, J. G. Parikh, and N. Rao, “Expression of α-crystallin in retinoblastoma,” Archives of Ophthalmology, vol. 127, no. 2, pp. 187–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Bleckmann, H. Geyer, A. Lieberoth et al., “O-glycosylation pattern of CD24 from mouse brain,” Biological Chemistry, vol. 390, no. 7, pp. 627–645, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Bleckmann, H. Geyer, V. Reinhold et al., “Glycomic analysis of N-linked carbohydrate epitopes from CD24 of mouse brain,” Journal of Proteome Research, vol. 8, no. 2, pp. 567–582, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Cremers, M. A. Deugnier, and J. Sleeman, “Loss of CD24 expression promotes ductal branching in the murine mammary gland,” Cellular and Molecular Life Sciences, vol. 67, no. 13, pp. 2311–2322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Liu, Y. Zhang, M. Liao et al., “Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma,” Pathology and Oncology Research, vol. 17, no. 1, pp. 45–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. O. Riener, A. Vogetseder, B. C. Pestalozzi et al., “Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract,” Human Pathology, vol. 41, no. 11, pp. 1558–1565, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. H. Lee, S. H. Kim, E. S. Lee, and Y. S. Kim, “CD24 overexpression in cancer development and progression: a meta-analysis,” Oncology Reports, vol. 22, no. 5, pp. 1149–1156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Wei, T. Yin, Z. Zhu, P. F. Shi, Y. Tian, and C. Y. Wang, “Expression of CD44, CD24 and esa in pancreatic adenocarcinoma cell lines varies with local microenvironment,” Hepatobiliary and Pancreatic Diseases International, vol. 10, no. 4, pp. 428–434, 2011. View at Google Scholar · View at Scopus
  12. X. R. Yang, Y. Xu, B. Yu et al., “CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery,” Clinical Cancer Research, vol. 15, no. 17, pp. 5518–5527, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Lee, D. I. Kim, C. Kwak, J. H. Ku, and K. C. Moon, “Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance,” Urology, vol. 72, no. 3, pp. 603–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. S. C. Smith and D. Theodorescu, “The ral gtpase pathway in metastatic bladder cancer: key mediator and therapeutic target,” Urologic Oncology, vol. 27, no. 1, pp. 42–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bektas, B. Bahadir, B. H. Ucan, and S. O. Ozdamar, “CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance,” Pathology and Oncology Research, vol. 16, no. 4, pp. 569–577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Wang, Q. Shi, Z. Wang et al., “Clinicopathologic correlation of cancer stem cell markers CD44, CD24, VEGF and HIF-1α in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study,” Pathology Research and Practice, vol. 207, no. 8, pp. 505–513, 2011. View at Publisher · View at Google Scholar
  17. J. B. Overdevest, S. Thomas, G. Kristiansen, D. E. Hansel, S. C. Smith, and D. Theodorescu, “CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization,” Cancer Research, vol. 71, no. 11, pp. 3802–3811, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Taniuchi, I. Nishimori, and M. A. Hollingsworth, “Intracellular CD24 inhibits cell invasion by posttranscriptional regulation of bart through interaction with g3bp,” Cancer Research, vol. 71, no. 3, pp. 895–905, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Kristiansen, E. MacHado, N. Bretz et al., “Molecular and clinical dissection of CD24 antibody specificity by a comprehensive comparative analysis,” Laboratory Investigation, vol. 90, no. 7, pp. 1102–1116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Fang, P. Zheng, J. Tang, and Y. Liu, “CD24: from A to Z,” Cellular and Molecular Immunology, vol. 7, no. 2, pp. 100–103, 2010. View at Publisher · View at Google Scholar
  21. N. Ikenaga, K. Ohuchida, K. Mizumoto et al., “Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas,” Human Pathology, vol. 41, no. 10, pp. 1466–1474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. Lee, G. Choe, S. Jheon, S. W. Sung, C. T. Lee, and J. H. Chung, “CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new tnm classification,” Journal of Thoracic Oncology, vol. 5, no. 5, pp. 649–657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Sano, H. Kato, S. Sakurai et al., “CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma,” Annals of Surgical Oncology, vol. 16, no. 2, pp. 506–514, 2009. View at Publisher · View at Google Scholar · View at Scopus